T1	Entity 132 141	proteases
T2	Entity 143 153	secretases
R1	is_subclass_of Arg1:T2 Arg2:T1	
T3	Entity 167 176	amyloid-β
T4	KeyEntity 178 180	Aβ
T5	Entity 199 224	amyloid precursor protein
T6	KeyEntity 226 229	APP
T7	Entity 318 335	Alzheimer disease
T8	Entity 366 388	reducing Aβ production
T9	Entity 510 534	repair of damaged tissue
T10	Entity 539 565	removal of amyloid lesions
R2	other_relation Arg1:T4 Arg2:T3	
#1	AnnotatorNotes R2	equivalent
R3	other_relation Arg1:T6 Arg2:T5	
#2	AnnotatorNotes R3	equivalent
R4	interacts_with Arg1:T6 Arg2:T7	
R5	participates_in Arg1:T8 Arg2:T9	
R6	participates_in Arg1:T8 Arg2:T10	
T11	KeyEntity 791 804	Aβ production
T12	Entity 867 889	overexpress mutant APP
T13	Entity 929 940	doxycycline
T14	Entity 1012 1039	fulminant amyloid pathology
T15	Entity 967 995	high-level expression of APP
T16	Entity 1054 1065	doxycycline
T17	Entity 1090 1115	transgenic APP expression
T18	Entity 1141 1161	educes Aβ production
T19	Entity 1216 1239	transgenic Aβ synthesis
T20	Entity 1288 1305	amyloid pathology
T21	Entity 1316 1344	formation and disaggregation
T22	Entity 1348 1364	amyloid deposits
T23	Entity 1381 1395	disequilibrium
T24	KeyEntity 1474 1487	APP synthesis
T25	KeyEntity 1546 1557	Aβ deposits
R7	regulates Arg1:T13 Arg2:T12	
R8	regulates Arg1:T15 Arg2:T14	
R9	regulates Arg1:T16 Arg2:T17	
R10	regulates Arg1:T16 Arg2:T18	
R11	participates_in Arg1:T19 Arg2:T20	
R12	participates_in Arg1:T21 Arg2:T22	
R13	participates_in Arg1:T22 Arg2:T23	
R14	interacts_with Arg1:T24 Arg2:T25	
T26	Entity 1674 1689	amyloid lesions
T27	Entity 1803 1826	arresting Aβ production
T28	Entity 1869 1889	halt the progression
T29	Entity 1913 1928	early treatment
T30	KeyEntity 1967 1983	amyloid deposits
T31	Entity 1713 1737	highly stable structures
T32	Entity 1755 1775	slow to disaggregate
R15	participates_in Arg1:T26 Arg2:T31	
R16	participates_in Arg1:T26 Arg2:T32	
R17	regulates Arg1:T27 Arg2:T28	
